植毛綿棒の製造を専門とするメーカー & CHG製品.
中国のCOVID-19経口薬が規制当局の承認を取得
2022-07-27
China’s top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
チャイナデイリー
多分あなたも好きです
著作権©2023. メディカルテクノロジー株式会社, 株式会社
